Compounds > technetium tc 99m hydroxymethylene diphosphonate
Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Retroperitoneal Neoplasms

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Retroperitoneal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamdan, A; Keller, A; Taylor, S; Toman, J1
Brown, JC; Haggstrom, JA1

Other Studies

2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Retroperitoneal Neoplasms

ArticleYear
Nuclear imaging of an extraskeletal retroperitoneal osteosarcoma: respective contribution of 18FDG-PET and (99m)Tc oxidronate (2005:1b).
    European radiology, 2005, Volume: 15, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Technetium Tc 99m Medronate

2005
False positive bone scan secondary to sympathectomy following resection of a ganglioneuroblastoma or affect of unilateral sympathectomy of bone scan in the pediatric patient.
    The Nebraska medical journal, 1988, Volume: 73, Issue:3

    Topics: Bone Neoplasms; Child, Preschool; Diagnostic Errors; False Positive Reactions; Ganglioneuroma; Humans; Radionuclide Imaging; Retroperitoneal Neoplasms; Sympathectomy; Technetium Tc 99m Medronate

1988